Results 211 to 220 of about 63,333 (299)

Frozen in Addiction: A New Wave of Drug‐Induced Movement Disorders?

Movement Disorders, EarlyView.
Christos Ganos, Roberto Erro, Mohammad Abdullah, Tanya S. Hauck, Daniel Ciccarone, Christy Sutherland, Parisa Saiyarsarai, Connie Marras, Susan H. Fox, Alfonso Fasano, Anthony E. Lang, Jonathan Squires, Kailash P. Bhatia   +12 more
wiley   +1 more source

Feasibility of Simon Two‐Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Disease‐modifying treatments are a critical unmet need in Parkinson's disease (PD). Phase 2 futility trials using the Simon two‐stage design offer an efficient strategy to evaluate candidate treatments in an early PD population. Objective The aim was to assess the feasibility of Simon two‐stage futility trials in early, levodopa ...
Marcus W. Koch, Lorraine V. Kalia, Justyna Sarna, Camila Aquino, Daryl Wile, Tiago A. Mestre, Michael G. Schlossmacher, Miguel D'Haeseleer, Jop Mostert, Eva M.M. Strijbis, Bernard Uitdehaag, Tarrant McPherson, Gary Cutter   +12 more
wiley   +1 more source

Longitudinal Trajectory of Multimodal Markers in a Patient with Isolated REM Sleep Behavior Disorder

Movement Disorders, EarlyView.
Seohee Choi, Ryul Kim, Kyung Ah Woo, Jung Hwan Shin, Eun Jin Yoon, Heejung Kim, Yu Kyeong Kim, Jee‐Young Lee   +7 more
wiley   +1 more source

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency

Movement Disorders, EarlyView.
Abstract Background Allan‐Herndon‐Dudley syndrome (AHDS)/monocarboxylate transporter 8 (MCT8) deficiency is a rare X‐linked encephalopathy caused by SLC16A2 variants, impairing thyroid hormone (TH) transport into the brain. This leads to early central nervous system (CNS) TH deficiency, affecting brain maturation.
Fabio Bruschi, Ylenia Vaia, Clara E. Antonello, Marco Spada, Francesco Porta, Cristina Marinaccio, Claudia Carducci, Thomas Opladen, Jacopo Sartorelli, Federica Maria Zibordi, Daniele Ghezzi, Francesco Nicita, Davide Tonduti   +12 more
wiley   +1 more source

Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy

, 2020
Jin Young Shin, Phil Hyu Lee
openalex   +1 more source

Multi‐Channel Neural Interface for Neural Recording and Neuromodulation

Small Methods, EarlyView.
This review highlights recent advances in multi‐channel neural interface technologies, covering both high‐resolution electrophysiological recording systems and multifunctional platforms with integrated capabilities. It also discusses innovations in structure and materials for reduced invasiveness, state‐of‐the‐art data analysis, including machine ...
Eunmin Kim, Won Gi Chung, Enji Kim, Myoungjae Oh, Joonho Paek, Taekyeong Lee, Dayeon Kim, Seung Hyun An, Sumin Kim, Jang‐Ung Park   +9 more
wiley   +1 more source

Atypical Parkinsonian Disorders—Clinical and Research Aspects Edited by Irene Litvan Human Press, 2005. ISBN 1-588-29-331-9. $175.00 [PDF]

, 2006
Jolyon Meara
openalex   +1 more source

Treatment of Neurogenic Voice Disorders

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT This overview serves as a foundational resource for clinicians caring for neurologically complex patients presenting with voice complaints. Neurogenic voice disorders are diverse in their clinical presentations and therapeutic approaches. A thorough medical history, including family history, detailed laryngeal examination, voice assessments ...
Mausumi Syamal
wiley   +1 more source

Atypical Parkinsonian Disorders: Clinical and Research Aspects. 2005. Edited by Irene Litvan. Published by Humana Press. 512 pages. Price C$225. [PDF]

, 2006
A. Jon Stoessl
openalex   +1 more source